RHSC annual return showed 36,850 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 36,850 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 485,880 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 485,880 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 629,697 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 629,697 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 682,732 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 682,732 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 354,276 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 354,276 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 123,998 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 123,998 units of commercial concentrate was used for haemophilia treatment.
RHSC annual return showed 62,315 units of commercial concentrate was used for haemophilia treatment. Read more about RHSC annual return showed 62,315 units of commercial concentrate was used for haemophilia treatment.
Glasgow Yorkhill Haemophilia Centre's annual returns showed substantial but decreasing use of commercial compared to PFC concentrates. Read more about Glasgow Yorkhill Haemophilia Centre's annual returns showed substantial but decreasing use of commercial compared to PFC concentrates.
Cryoprecipitate, although less convenient to use, was not impracticable for home treatment despite what the opinion at Yorkhill hospital was. Read more about Cryoprecipitate, although less convenient to use, was not impracticable for home treatment despite what the opinion at Yorkhill hospital was.
Dr Pettigrew viewed that all clinical staff acted in what they thought to be in the best interests of their patients, including Dr Willoughby (who instituted home therapy with Factor VIII concentrates. Read more about Dr Pettigrew viewed that all clinical staff acted in what they thought to be in the best interests of their patients, including Dr Willoughby (who instituted home therapy with Factor VIII concentrates.